Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by abhimanyu – Banglore, 2019-08-13 17:11 (1715 d 17:25 ago) – Posting: # 20494
Views: 2,420

Hello Helmut/All,

I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.

How can we find outlier? which one will be appropriate scenario for any regulatory point of view?

Scenario 1 : can we use test and individual reference (R R) to calculate standardized residual?

Scenario 2 : Can we use test and average of reference (average of R R) to calculate standardized residual?




Thanks in advance!

Abhimanyu

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,659 registered users;
66 visitors (0 registered, 66 guests [including 3 identified bots]).
Forum time: 10:36 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5